Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Caulfield who wrote (77)	1/19/1999 12:03:00 PM
From: Mike McFarland	Read Replies (1) of 946

thread: Former Chiron Executive Appointed Chief Operating Officer at Cell Therapeutics Inc. biz.yahoo.com ''Ed will play an important role in establishing new strategic development and commercial alliances and in transitioning cti from a late stage development organization to a commercial operating company. His experience will help us maximize our oncology product portfolio expansions of 1998, including PG-TXL (polyglutamate paclitaxel), a novel, potentially more effective form of the well known cancer drug, Taxol® and SC-7, a novel oral anti-angiogenic agent,'' said James A. Bianco, MD, President and CEO of Cell Therapeutics Inc. ''Further, Ed will be instrumental in 1999 in helping us take two cti products (lisofylline and CT-2584) through pivotal trials and NDA filing preparation,'' Dr. Bianco noted. eom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next